Utama › Nefrosis Lipoid › North Carolina
Kajian klinikal Nefrosis Lipoid di North Carolina
4 kajian untuk Nefrosis Lipoid sedang mencari peserta di lokasi di North Carolina.
Bandar di North Carolina
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- UNC Kidney Center- Site Number : 8400021, Chapel Hill
Mengambil pesertaFasa 2
Umur 16 hingga 75 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06500702Nephrotic Syndrome Study Network
- University of North Carolina at Chapel Hill, Chapel Hill
- Atrium Health Levine Children's Hospital, Charlotte
Mengambil pesertaKajian pemerhatian
Sehingga umur 80 · Semua jantina · Dikemas kini 10 Jun 2026 · NCT01209000NEPTUNE Match Study
- University of North Carolina Chapel Hill, Chapel Hill
Mengambil peserta
Umur 1 hingga 80 · Semua jantina · Dikemas kini 10 Jun 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke Molecular Physiology Institute, Durham
Mengambil pesertaFasa 2
Umur 1 hingga 17 · Semua jantina · Dikemas kini 12 Mei 2026 · NCT05003986Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.